Recent developments in fish vaccinology.

During the last 10 to 20 years vaccination has become established as an important method for prevention of infectious diseases in farmed fish, mainly salmonid species. So far, most commercial vaccines have been inactivated vaccines administered by injection or immersion. Bacterial infections caused by Gram-negative bacteria such as Vibrio sp., Aeromonas sp., and Yersinia sp. have been effectively controlled by vaccination. With furunculosis, the success is attributed to the use of injectable vaccines containing adjuvants. Vaccines against virus infections, including infectious pancreatic necrosis, have also been used in commercial fish farming. Vaccines against several other bacterial and viral infections have been studied and found to be technically feasible. Pasteurellosis, streptococcosis (lactococcosis) and infections with iridoviruses are candidate diseases for control by immunoprophylaxis in the near future. The overall positive effect of vaccination in farmed fish is reduced mortality. However, for the future of the fish farming industry it is also important that vaccination contributes to a sustainable biological production with negligible consumption of antibiotics. A potential side-effect associated with injectable vaccines is local reactions in the peritoneal cavity. The paper presents recent developments in immunoprophylaxis of fish and some problems that should be addressed by the research community in the years to come.

[1]  A. Lillehaug,et al.  Passive transfer of specific maternal immunity does not protect Atlantic salmon (Salmo salarL.) fry against yersiniosis , 1996 .

[2]  P. Midtlyng,et al.  Growth of Atlantic salmon Salmo salar after intraperitoneal administration of vaccines containing adjuvants. , 1998, Diseases of aquatic organisms.

[3]  T. Foster,et al.  Potency testing of a live, genetically attenuated vaccine for salmonids. , 1998, Vaccine.

[4]  P. Frost,et al.  Vaccination of Atlantic salmon with recombinant VP2 of infectious pancreatic necrosis virus (IPNV), added to a multivalent vaccine, suppresses viral replication following IPNV challenge. , 1997 .

[5]  J. Rombout,et al.  Oral vaccination of fish againstVibrio anguillarumusing alginate microparticles , 1997 .

[6]  C. Secombes,et al.  Fish immune responses to experimental and natural infection with helminth parasites , 1996 .

[7]  P. Klesius,et al.  Protective immunity against enteric septicaemia in channel catfish, Ictalurus punctatus (Rafinesque), following controlled exposure to Edwardsiella ictaluri , 1997 .

[8]  P. Midtlyng,et al.  Protection, immune responses and side effects in Atlantic salmon (Salmo salarL.) vaccinated against furunculosis by different procedures , 1996 .

[9]  M. Landolt,et al.  Route of vaccine administration: effects on the specific humoral response in rainbow trout Oncorhynchus mykiss. , 1998, Diseases of aquatic organisms.

[10]  N. J. Olesen,et al.  Molecular cloning and expression in Escherichia coli of the glycoprotein gene of VHS virus, and immunization of rainbow trout with the recombinant protein. , 1993, The Journal of general virology.

[11]  J. Fryer,et al.  Viral vaccines for aquaculture , 1993 .

[12]  L. Babiuk,et al.  Novel viral vaccines for livestock. , 1996, Veterinary immunology and immunopathology.

[13]  H. Davis,et al.  Protective immunity to VHS in rainbow trout (Oncorhynchus mykiss, Walbaum) following DNA vaccination , 1998 .

[14]  A. Ellis,et al.  Antibody response and protection of Atlantic salmon (Salmo salar) immunised with an extracellular polysaccharide ofAeromonas salmonicida , 1997 .

[15]  D. Alderman,et al.  World wide aquaculture drug and vaccine registration progress , 1997 .

[16]  J. Harris,et al.  The immunocytochemical localisation of potential candidate vaccine antigens from the salmon louse Lepeophtheirus salmonis (Kroyer 1837) , 1995 .

[17]  T. Foster,et al.  A live (delta aroA) Aeromonas salmonicida vaccine for furunculosis preferentially stimulates T-cell responses relative to B-cell responses in rainbow trout (Oncorhynchus mykiss) , 1996, Infection and immunity.

[18]  H. Mikkelsen,et al.  Immunocompetence and duration of immunity againstVibrio salmonicidaandAeromonas salmonicidaafter vaccination of Atlantic salmon (Salmo salarL.) at low and high temperatures , 1997 .

[19]  T. Trust,et al.  Recombinant infectious hematopoietic necrosis virus and viral hemorrhagic septicemia virus glycoprotein epitopes expressed in Aeromonas salmonicida induce protective immunity in rainbow trout (Oncorhynchus mykiss) , 1995, Applied and environmental microbiology.

[20]  M. Ototake,et al.  Particulate antigen uptake during immersion immunisation of fish: The effectiveness of prolonged exposure and the roles of skin and gill , 1998 .

[21]  K. Nakajima,et al.  Vaccination Against Red Sea Bream Iridoviral Disease in Red Sea Bream , 1997 .

[22]  S. Gudmundsdóttir,et al.  Evaluation of cross protection by vaccines against atypical and typical furunculosis in Atlantic salmon, Salmo salar L. , 1997 .

[23]  L. Johansen,et al.  Bivalent vaccines for sea bass (Dicentrachus labrax) against vibriosis and pasteurellosis , 1998 .

[24]  A. Lillehaug,et al.  Adjuvant activity of polar glycopeptidolipids fromMycobacterium chelonaein experimental vaccines againstAeromonas salmonicidain salmonid fish , 1997 .

[25]  C. Press,et al.  Vaccination in European salmonid aquaculture: a review of practices and prospects. , 1995, The British veterinary journal.

[26]  Patrick T.K. Woo.  Protective immune response of fish to parasitic flagellates , 1996 .

[27]  J. Hata,et al.  Mother to fry, successful transfer of immunity against infectious haematopoietic necrosis virus infection in rainbow trout. , 1996, The Journal of general virology.

[28]  S. Newman.  Bacterial vaccines for fish , 1993 .

[29]  R. Thune,et al.  A Comparison of Immersion, Immersion/Oral Combination and Injection Methods for the Vaccination of Channel Catfish Ictalurus punctatus Against Edwardsiella ictaluri , 1997 .

[30]  J. Lamas,et al.  Efficacy of intraperitoneal and immersion vaccination against Enterococcus sp. infection in turbot , 1995 .

[31]  A. Lillehaug,et al.  Immunological cross reactions betweenAeromonas salmonicidaandVibrio salmonicidain Atlantic salmon (Salmo salarL.) and rabbit , 1998 .

[32]  G. Iwama,et al.  Specific protective activity demonstrated in eggs of broodstock salmon injected with rabbit antibodies raised against a fish pathogen , 1997 .

[33]  T. J. Lam,et al.  Passive transfer of protective immunity against ichthyophthiriasis from vaccinated mother to fry in tilapias, Oreochromis aureus , 1994 .

[34]  V. Steinthorsdottir,et al.  Survival and humoral antibody response of Atlantic salmon, Salmo salar L., vaccinated against Aeromonas salmonicida ssp. achromogenes. , 1997 .

[35]  C. Nash,et al.  Sustainable fish farming , 1996 .

[36]  P. Midtlyng,et al.  Experimental studies on the efficacy and side-effects of intraperitoneal vaccination of Atlantic salmon (Salmo salarL.) against furunculosis , 1996 .

[37]  H. Sørum.  Mobile drug resistance genes among fish bacteria. , 1998, APMIS. Supplementum.

[38]  I. Dalsgaard,et al.  Occurrence and significance of atypical Aeromonas salmonicida in non-salmonid and salmonid fish species: a review. , 1998, Diseases of aquatic organisms.

[39]  O. Breck,et al.  Pathology of Atlantic salmon Salmo salar intraperitoneally immunized with oil-adjuvanted vaccine. A case report , 1997 .

[40]  P. Midtlyng.  A field study on intraperitoneal vaccination of Atlantic salmon (Salmo salarL.) against furunculosis , 1996 .